Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 21 peer-reviewed journal articles Updated
Otolaryngology

The Diagnostic Journey: Tests and Imaging

At a Glance

Endolymphatic hydrops is evaluated by combining symptom history, serial hearing tests, and selected balance tests or delayed-contrast inner-ear MRI. No single test confirms Ménière’s disease, and normal supportive tests do not rule it out.

The diagnosis of endolymphatic hydrops and Ménière’s disease is often a process of “connecting the dots” rather than a single definitive test. Because the inner ear is encased in the hardest bone in the human body, doctors cannot simply biopsy it. Instead, they rely on a combination of your clinical history, hearing tests, and specialized imaging to build a complete picture.

The Foundation: Clinical Diagnosis

Despite advances in technology, the most important diagnostic tool is your own story. International consensus (from the Bárány Society and AAO-HNS) defines the diagnosis primarily through symptoms and hearing tests [1][2]:

  • Definite Ménière’s Disease: Requires at least two spontaneous episodes of vertigo (20 minutes to 12 hours), documented low-to-medium frequency hearing loss in one ear, and fluctuating symptoms like tinnitus or fullness [2].
  • Probable Ménière’s Disease: Focuses on the vertigo episodes (20 minutes to 24 hours) and fluctuating ear symptoms, but may not yet have documented hearing loss on an audiogram [2].

The audiogram (hearing test) is central because it documents the hearing loss and its progression. Because hearing can change, serial audiograms—taking tests at different times—are used to capture the fluctuation that defines hydrops [3][4].

Specialized Imaging: The “Hydrops MRI”

A standard MRI of the brain is often ordered to rule out other issues, such as a tumor on the hearing nerve (acoustic neuroma) [5]. To actually visualize the fluid buildup, a specific protocol called delayed-contrast inner-ear MRI is used selectively [6].

  • The Protocol: You receive an injection of a contrast agent (gadolinium). You then wait approximately four hours before the scan begins [6]. This delay allows the contrast to seep into the perilymph (the outer fluid) but not the endolymph (the inner fluid).
  • The Result: On a high-resolution 3-Tesla MRI, the contrast-filled perilymph glows, while the endolymph-filled compartments remain dark. This allows radiologists to see if the dark areas are “ballooning” or taking up more space than they should [7][8].
  • The Grading: Doctors use scales (like the Baráth or Bernaerts scales) to “grade” the hydrops from mild to severe [8].

It is vital to know that this MRI is not mandatory for everyone. While helpful, these scans are “supportive”—meaning you can have hydrops on an MRI but not have Ménière’s, or vice versa, and protocols and scanner strengths vary [9][10].

Supportive “Function” Tests

Other tests measure how well different parts of your inner ear are working. These are supportive tools, and their sensitivity and specificity vary depending on technique, age, and hearing status; a normal result does not exclude the condition [11].

  • Electrocochleography (ECochG): This measures electrical potentials in the inner ear in response to sound. A high “SP/AP ratio” can suggest hydrops, but the test’s performance is highly variable [12][13].
  • VEMPs (Vestibular Evoked Myogenic Potentials): These tests use sound or vibration to check the health of the saccule and utricle (the gravity-sensing parts of your ear). They are highly specific but can often be normal [14][15].
  • Caloric Testing: This involves putting warm or cool water/air in the ear canal to stimulate the balance sensors. Discrepancies between this test and the vHIT (another balance test) can occur, but this is a possible pattern, not an expected requirement [16][17].

Tests Your Doctor May Consider

Ménière’s disease is primarily a clinical and audiometric diagnosis. Your clinician may selectively order the following:

  1. Serial Audiograms: Hearing tests performed over time to document hearing status and capture fluctuation [4].
  2. MRI: A standard internal auditory canal MRI to rule out other disease, or a delayed post-gadolinium protocol to visualize hydrops (which requires screening for kidney issues and pregnancy) [6].
  3. Differential Review: A formal discussion to distinguish symptoms from vestibular migraine, BPPV, or stroke [18][19].
  4. Vestibular Battery: Supportive tests (VEMP, caloric, vHIT) to characterize function or plan for treatment [20][21].

Common questions in this guide

How do doctors diagnose endolymphatic hydrops?
Doctors combine your history of vertigo and ear symptoms with hearing-test results, especially an audiogram. Serial audiograms may be used because hearing can fluctuate, and no single test definitively diagnoses endolymphatic hydrops or Ménière’s disease.
What can a delayed-contrast MRI show in endolymphatic hydrops?
A delayed-contrast inner-ear MRI uses gadolinium and a waiting period of about four hours to make the perilymph visible while the endolymph-filled spaces remain dark. A high-resolution scan can show whether those spaces are enlarged and help grade hydrops, but the result is supportive rather than definitive.
Can a normal ECochG or VEMP test rule out endolymphatic hydrops?
No. ECochG and VEMP results can be normal even when endolymphatic hydrops or Ménière’s disease is present because test performance varies with the technique, age, and hearing status. Doctors interpret these tests together with symptoms, audiograms, and other findings.
What is the difference between a standard MRI and a hydrops MRI?
A standard brain or internal auditory canal MRI is often used to look for other causes of symptoms, such as an acoustic neuroma. A delayed-contrast inner-ear MRI uses a specialized protocol to visualize fluid compartments and possible hydrops, and it may require screening for kidney problems and pregnancy.
How do doctors tell Ménière’s disease apart from vestibular migraine?
They compare the timing and features of vertigo episodes with hearing changes, tinnitus, ear fullness, migraine history, and possible triggers. Audiograms, imaging, and vestibular tests can support the evaluation, but the distinction is based on the overall clinical picture rather than one test.
What is the difference between definite and probable Ménière’s disease?
Definite Ménière’s disease includes at least two spontaneous vertigo episodes lasting 20 minutes to 12 hours, documented low- to medium-frequency hearing loss in one ear, and fluctuating ear symptoms such as tinnitus or fullness. Probable Ménière’s disease involves qualifying vertigo and fluctuating ear symptoms but may not yet include documented hearing loss.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my hearing tests, do I meet the 'definite' or 'probable' Bárány Society criteria for Ménière's disease?
  2. 2.Is the MRI you are ordering a standard brain scan, or a 3-Tesla 'delayed-contrast' protocol designed specifically to visualize hydrops?
  3. 3.If my ECochG or VEMP tests come back normal, does that rule out hydrops, or can those tests be negative even when the condition is present?
  4. 4.Since my symptoms overlap with vestibular migraine, how are we using these test results to distinguish between the two?
  5. 5.Can you explain my 'hydrops grade' from the MRI and how it correlates with my current level of hearing loss?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (21)
  1. 1

    Diagnostic criteria for Menière's disease.

    Lopez-Escamez JA, Carey J, Chung WH, et al.

    Journal of vestibular research : equilibrium & orientation 2015; (25(1)):1-7 doi:10.3233/VES-150549.

    PMID: 25882471
  2. 2

    [Diagnostic criteria for Menière's disease according to the Classification Committee of the Bárány Society].

    Lopez-Escamez JA, Carey J, Chung WH, et al.

    HNO 2017; (65(11)):887-893 doi:10.1007/s00106-017-0387-z.

    PMID: 28770282
  3. 3

    Magnetic resonance imaging and Ménière's disease-unavoidable alliance.

    Sousa R, Raposo F, Guerreiro C, et al.

    Neuroradiology 2021; (63(11)):1749-1763 doi:10.1007/s00234-021-02744-5.

    PMID: 34142211
  4. 4

    Menière's disease.

    Espinosa-Sanchez JM, Lopez-Escamez JA

    Handbook of clinical neurology 2016; (137()):257-77.

    PMID: 27638077
  5. 5

    Imaging endolymphatic space of the inner ear in vestibular migraine.

    Kirsch V, Boegle R, Gerb J, et al.

    Journal of neurology, neurosurgery, and psychiatry 2025; (96(5)):415-423 doi:10.1136/jnnp-2024-334419.

    PMID: 39271244
  6. 6

    A systematic review on delayed acquisition of post-gadolinium magnetic resonance imaging in Ménière's disease: imaging of the endolymphatic spaces.

    Han A, Kontorinis G

    The Journal of laryngology and otology 2023; (137(3)):239-245 doi:10.1017/S0022215122001347.

    PMID: 35674257
  7. 7

    Comparison of gadolinium-enhanced MRI of the inner ear with definite Meniere's disease in the detection of endolymphatic hydrops between intratympanic and intravenous injection.

    Huang J, Tang C, Li W, et al.

    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 2025; (282(8)):4029-4040 doi:10.1007/s00405-025-09334-8.

    PMID: 40220180
  8. 8

    Endolymphatic hydrops evaluation on MRI: Practical considerations.

    Loureiro RM, Sumi DV, Tames HLVC, et al.

    American journal of otolaryngology 2020; (41(2)):102361 doi:10.1016/j.amjoto.2019.102361.

    PMID: 31784143
  9. 9

    The "hype" of hydrops in classifying vestibular disorders: a narrative review.

    van der Lubbe MFJA, Vaidyanathan A, Van Rompaey V, et al.

    Journal of neurology 2020; (267(Suppl 1)):197-211 doi:10.1007/s00415-020-10278-8.

    PMID: 33201310
  10. 10

    [New developments in inner ear imaging for Meniere's disease].

    Gerb J

    HNO 2026; (74(8)):492-499 doi:10.1007/s00106-025-01708-y.

    PMID: 41498927
  11. 11

    Assessment Tools for Use in Patients with Ménière Disease: An Update.

    Ciorba A, Skarżyński PH, Corazzi V, et al.

    Medical science monitor : international medical journal of experimental and clinical research 2017; (23()):6144-6149 doi:10.12659/msm.905166.

    PMID: 29282350
  12. 12

    Comparing the sensitivity and specificity of cervical vestibular-evoked myogenic potentials and electrocochleography in the diagnosis of Ménière's disease.

    Obeidat FS, Lewis Bell S

    International journal of audiology 2019; (58(11)):738-746 doi:10.1080/14992027.2019.1627008.

    PMID: 31204531
  13. 13

    MRI Inner Ear Imaging and Tone Burst Electrocochleography in the Diagnosis of Ménière's Disease.

    Hornibrook J, Flook E, Greig S, et al.

    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2015; (36(6)):1109-14 doi:10.1097/MAO.0000000000000782.

    PMID: 25985318
  14. 14

    Diagnostic Value of Vestibular Evoked Myogenic Potentials in Endolymphatic Hydrops: A Meta-Analysis.

    Zhang S, Leng Y, Liu B, et al.

    Scientific reports 2015; (5()):14951 doi:10.1038/srep14951.

    PMID: 26455332
  15. 15

    Is Alteration of Tuning Property in Cervical Vestibular-Evoked Myogenic Potential Specific for Ménière's Disease?

    Murofushi T, Tsubota M, Suizu R, Yoshimura E

    Frontiers in neurology 2017; (8()):193 doi:10.3389/fneur.2017.00193.

    PMID: 28533763
  16. 16

    Dissociation of caloric and head impulse tests: a marker of Meniere's disease.

    Hannigan IP, Welgampola MS, Watson SRD

    Journal of neurology 2021; (268(2)):431-439 doi:10.1007/s00415-019-09431-9.

    PMID: 31222419
  17. 17

    Differential Involvement of Lateral Semicircular Canal and Otolith Organs in Common Vestibular Disorders.

    Kim Y, Kang BC, Yoo MH, Park HJ

    Frontiers in neurology 2022; (13()):819385 doi:10.3389/fneur.2022.819385.

    PMID: 35173674
  18. 18

    Update on diagnosis and differential diagnosis of vestibular migraine.

    Shen Y, Qi X

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2022; (43(3)):1659-1666 doi:10.1007/s10072-022-05872-9.

    PMID: 35015204
  19. 19

    [Diagnosis and treatment of vestibular migraine - recent developments and future treatment strategies].

    Tarnutzer AA, Dlugaiczyk J

    Laryngo- rhino- otologie 2026; doi:10.1055/a-2881-5957.

    PMID: 42335970
  20. 20

    Vestibular function analysis in patients with unilateral Ménière's disease.

    Liu X, Shi S, Gao W, Wang W

    European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 2026; (283(5)):2917-2925 doi:10.1007/s00405-026-10011-7.

    PMID: 41622266
  21. 21

    Vestibular migraine or Meniere's disease: a diagnostic dilemma.

    Chen JY, Guo ZQ, Wang J, et al.

    Journal of neurology 2023; (270(4)):1955-1968 doi:10.1007/s00415-022-11532-x.

    PMID: 36562849

This page is for informational purposes only and does not constitute medical advice. An ear specialist should interpret your hearing tests and imaging alongside your symptoms and medical history.

Get notified when new evidence is published on endolymphatic hydrops.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.